Could a 'happy pill' ever become a reality?

The nature of happiness is a topic of intense discussion. Is it defined by the lack of pain or the abundance of joy? Does it stem from leading a purposeful life? Or is happiness merely a brain-driven reaction to external factors, a surge of neurotransmitters released by specific cells that creates feelings of joy and overall wellbeing?

If happiness is indeed an electrochemical phenomenon—and evidence increasingly supports this idea—then it should be possible to control it. In the future, for example, we might develop a pill capable of replicating the effects of positive experiences, such as falling in love or enjoying a series of uplifting events.

A large segment of the population might reject the idea of a 'happy pill,' even if it were to exist. A 2006 study in Great Britain revealed that 72 percent of respondents were against using a hypothetical legal drug designed to induce happiness without side effects [source: Easton]. But how would we define such a 'happy pill'? Would it even be marketed as such?

The 'happy pill' imagined in the 2006 survey might already exist, and its legal status may have already shifted. Many know this substance as MDMA or Ecstasy.

Originally created in 1914 by a Merck pharmaceutical researcher, MDMA was intended as a chemical catalyst. However, within 70 years, it was repurposed as a psychotherapeutic tool, capable of unlocking intense emotions beneficial for psychological recovery.

MDMA prompts the brain to release serotonin and dopamine, neurotransmitters linked to mood stability and a sense of wellbeing. Therapists observed that the surge of these chemicals induced feelings of empathy, joy, and openness in patients, making it especially effective for trauma survivors addressing suppressed memories. The drug acted as an emotional facilitator.

Research into MDMA has been thorough yet cautious. The CIA explored its potential as a brainwashing tool in the 1950s. In the 1970s, a Dow Chemical employee reintroduced the drug and documented its euphoric effects. By the 1980s, psychiatrists were using it therapeutically, but by 1985, it was banned in the United States.

The two legislative acts were primarily influenced by research from a single scientist, who claimed that MDMA leads to permanent brain damage. However, the second pivotal study was entirely withdrawn by the researcher when it was revealed that he had mistakenly administered methamphetamine instead of MDMA to the test monkeys [source: Bailey]. With a revised understanding that the drug may not be as dangerous as once thought, the psychiatric field is revisiting MDMA's potential for therapeutic applications, particularly in treating post-traumatic stress disorder.

Although MDMA doesn't perfectly match the ideal of a "happy pill" as imagined in a 2006 survey—being illegal and causing mood dips as the brain replenishes its neurotransmitters—it still comes close for many. Considering MDMA as the nearest approximation to a genuine "happy pill" offers insights into societal perceptions of happiness. Despite its prohibition and the stigma attached to its users, it appears that the majority believe happiness cannot be artificially manufactured.